Nvidia's third-quarter financial results on Wednesday surpassed analyst expectations, signaling that demand for its artificial intelligence chips remains robust amid investor concerns about an AI ...

Note: Compounded drugs are not approved by the U.S. Food and Drug Administration (FDA) and may carry greater risks than FDA-approved treatments. In April 2025, the U.S. Food and Drug Administration ...

Forbes contributors publish independent expert analyses and insights. Wayne Winegarden covers the economic impacts of regulatory policies The new class of GLP-1 medicines exemplifies both the ...

Quarterly or twice a year? If you find your friends suddenly arguing about the frequency of financial reporting for listed companies, and you feel left out for lacking strong opinions on the matter, I ...

Donald Trump is no fan of checks on executive power in government. Now, he’s going after one of the checks on corporate executive power: the requirement to report every quarter. His arguments, in a ...

President Trump says he wants to ditch a staple of U.S. financial markets: quarterly earnings reports. If Mr. Trump's push is successful, the change would eliminate a requirement that's been in place ...

President Donald Trump suggested on Monday that U.S. public companies should shift from filing quarterly earnings reports to reporting on a semiannual basis, arguing the change would cut costs and ...

President Donald Trump said he thinks U.S. companies should report earnings every six months instead of quarterly, a controversial change that would disrupt longstanding practice and requires approval ...

This article reviews the safety, efficacy, and regulatory concerns related to compounded semaglutide, with a focus on how health care providers can offer guidance and education to patients.

Novo Nordisk's shares plunged more than 20% Tuesday, after the company cut the forecast for its flagship obesity drug. Before the markets opened, the company announced that sales of its obesity ...

A compounding pharmacy in Amherst is in trouble with the law after hiring a third-party company to help get prescriptions approved by insurers, including Medicare, with many of them allegedly being ...